Journal Watch · Nature Communications · 2026
Concise synthesis of bufogargarizin B by a conformation-controlled skeletal reorganization approach.
This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
TL;DR
This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
Key findings
- This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
What they did
The synthesis features the rapid construction of the 5/7/6/5 tetracyclic core framework by means of a SmI<sub>2</sub>-mediated ketone-allylic acetate transannular cyclization, and the installation of stereochemically diverse 5,7- and 7,5-fused ring systems through a biomimetic retro-aldol/transannular aldol cascade reaction. In addition, an efficient, scalable synthesis of 2-pyrone-5-boronate, a key building block for the introduction of the side chain of bufadienolides, has been developed, and the highly functionalized all-cis D ring of bufogargarizin B is installed by means of a series of highly chemo- and regioselective redox transformations.
Full abstract (original)
Background: Bufogargarizins are a class of unique 19-norbufadienolides isolated from the venom of Bufo bufo gargarizans. Here we report a concise synthesis of bufogargarizin B from inexpensive, commercially available dehydroepiandrosterone by means of a conformation-controlled skeletal reorganization approach.
What they did: The synthesis features the rapid construction of the 5/7/6/5 tetracyclic core framework by means of a SmI<sub>2</sub>-mediated ketone-allylic acetate transannular cyclization, and the installation of stereochemically diverse 5,7- and 7,5-fused ring systems through a biomimetic retro-aldol/transannular aldol cascade reaction. In addition, an efficient, scalable synthesis of 2-pyrone-5-boronate, a key building block for the introduction of the side chain of bufadienolides, has been developed, and the highly functionalized all-cis D ring of bufogargarizin B is installed by means of a series of highly chemo- and regioselective redox transformations.
Results & conclusions: This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
Abstract © the authors / Nature Communications (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41467-026-70735-2 · PubMed 41851127.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Nature Communications for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Nature Communications study find?
This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
What type of study is this?
It is a research study, published in Nature Communications in 2026. The synthesis features the rapid construction of the 5/7/6/5 tetracyclic core framework by means of a SmI<sub>2</sub>-mediated ketone-allylic acetate transannular cyclization, and the installation of stereochemically diverse 5,7- and 7,5-fused ring systems through a biomimetic retro-aldol/transannular aldol cascade reaction.
Where can I read the original paper?
The original is at the publisher via DOI 10.1038/s41467-026-70735-2. PubMed ID: 41851127. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/concise-synthesis-of-bufogargarizin-b-by-a-conformation-controlled-skele-707352/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides